DoH, Hayat Biotech collaborate to enhance pharmaceutical industry in emirate

Hayat Biotech, a joint venture between G42 and Chinese pharmaceutical group Sinopharm CNBG, and the Department of Health – Abu Dhabi (DoH) have signed a declaration of collaboration aimed at strengthening the emirate’s efforts in R&D, clinical research, and its manufacturing capabilities. The co...